Is ImmuCell Corporation's (NASDAQ:ICCC) Recent Price Movement Underpinned By Its Weak Fundamentals? [Yahoo! Finance]
ImmuCell Corporation (ICCC)
US:NASDAQ Investor Relations:
immucell.com/investors
Company Research
Source: Yahoo! Finance
completely ignored the positive aspects of the company's fundamentals and decided to weigh-in more on the negative aspects. Stock prices are usually driven by a company's financial performance over the long term, and therefore we decided to pay more attention to the company's financial performance. Specifically, we decided to study ImmuCell's ROE in this article. Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Put another way, it reveals the company's success at turning shareholder investments into profits. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. How To Calculate Return On Equity? The formula for return on equity is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So,
Show less
Read more
Impact Snapshot
Event Time:
ICCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICCC alerts
High impacting ImmuCell Corporation news events
Weekly update
A roundup of the hottest topics
ICCC
News
- ImmuCell's Two-Product Edge in Cattle Health Fuels Growth [Yahoo! Finance]Yahoo! Finance
- ImmuCell (NASDAQ:ICCC) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- ImmuCell signals operational excellence and targets $30M annual production capacity amid management transition [Seeking Alpha]Seeking Alpha
- ImmuCell Corporation (ICCC) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025GlobeNewswire
ICCC
Sec Filings
- 12/4/25 - Form 4/A
- 12/3/25 - Form 4
- 11/28/25 - Form 4
- ICCC's page on the SEC website